U.S. DISTRICT COURT No. 2924 Document 868 Filed 10/25/21 Page 1 of 2 DISTRICT ARKANSAS Oct 25, 2021 UNITED STATES JUDICIAL PANEL on AERLDOWNE TILER MULTIDISTRICT LITIGATION JakeKornegay D.C. DEP CLERK IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION MDL No. 2924

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO —79)

On February 6, 2020, the Panel transferred 12 civil action(s) to the United States District Court for the Southern District of Florida for coordinated or consolidated pretrial proceedings pursuant to

. See

(J.P.M.L. 2020). Since that time, 361 additional action(s) have been transferred to the Southern District of Florida. With the consent of that court, all such actions have been assigned to the Honorable Robin L. Rosenberg. It appears that the action(s) on this conditional transfer order involve questions of fact that are common to the actions previously transferred to the Southern District of Florida and assigned to Judge Rosenberg. Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation, the action(s) on the attached schedule are transferred under

to the Southern District of Florida for the reasons stated in the order of February 6, 2020, and, with the consent of that court, assigned to the Honorable Robin L. Rosenberg. This order does not become effective until it is filed in the Office of the Clerk of the United States District Court for the Southern District of Florida. The transmittal of this order to said Clerk shall be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the Panel within this 7-day period, the stay will be continued until further order of the Panel.

Inasmuch as no objection i FOR THE PANEL: jection is pending at this time, the stay is lifted. Cf Oct 25, 2021 ( Che John W. Nichols MULTIDISTRICT IITIGATION Clerk of the Panel RTES DIST Certified to be a true and ie OP correct copy of the document on file . ae Souther District of Florida 2) he alll □ ‘S/ By Maria Cruz ep ae 5 De 39°" drgTRck Date _Oct 25, 2021.

VY ee TIA Ve Vee A A RUPP Pave Bee PRN OZ rw RAN LO oe oe t □ □□ Case MDL No. 2924 Document 868 Filed 10/25/21 Page 2 of 2

IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION MDL No. 2924

SCHEDULE CTO—79 — TAG-ALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

ARKANSAS EASTERN ARE 4 2100923 Talbert v. Boehringer Ingeleim Pharmaceuticals Inc et al PENNSYLVANIA EASTERN $MORMLB HS BOFHRAIS ERIC ELHEB PAE 2 2447S PHARMACEUTICAESING ete} Opposed 10/20/2021 PAE 2 24-94496 KMIECIAK + GLAXOSMITHKLINE LLC o¢ gl Opposed 10/2 DALICANDRO+ BOEHRINGER INGELHEIM PAE 2 24-4482 PHARMACEUTICATS ING BT At” Opposed 10/20/2021 ROBERTO HMENEZ + BOEHRINGER INGELHEIM PAE 3 2445+ PHARMACEUTICALS ING 1 ? ° Opposed 10/20/2021